• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers develop novel method for glucagon delivery

Bioengineer by Bioengineer
July 20, 2021
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Notre Dame

For children with Type 1 diabetes, the risk of experiencing a severe hypoglycemic episode is especially common — and for parents, the threat of that happening in the middle of the night is especially frightening. Sudden and critical drops in blood sugar can go undetected overnight when the child is asleep, resulting in coma and death — an event known as “dead in bed syndrome.”

“A parent can check their child’s glucose levels right before they go to bed and everything looks fine, then around 2 a.m. their blood sugar is dangerously low — near comatose level,” said Matthew Webber, associate professor of chemical and biomolecular engineering at the University of Notre Dame.

Webber has listened to parents of diabetic children describe the fear of such an episode — waking up several times a night to check glucose levels and the panic of emergency situations and rushing children to the hospital in the middle of the night.

In severe situations, glucagon injections can stabilize blood glucose levels long enough for parents to get their child medical attention. But in a new study, published in the Journal of the American Chemical Society, Webber is rethinking the traditional use of glucagon as an emergency response by administering it as a preventive measure.

In the research, Webber and his team illustrate how they successfully developed hydrogels that remain intact in the presence of glucose but slowly destabilize as levels drop, releasing glucagon into the system, raising glucose levels.

“In the field of glucose-responsive materials, the focus has typically been on managing insulin delivery to control spikes in blood sugar,” Webber said. “There are two elements to blood glucose control. You don’t want your blood sugar to be too high and you don’t want it to be too low. We’ve essentially engineered a control cycle using a hydrogel that breaks down when glucose levels drop to release glucagon as needed.”

The gels are water-based with a three-dimensional structure. Webber describes them as having a mesh-like architecture resembling a pile of spaghetti noodles with glucagon “sprinkled” throughout. According to the study, in animal models the gels dissolved as glucose levels dropped, eventually breaking down to release their glucagon contents.

Ideally in future applications, the gels would be administered each night before bed, Webber explained. “If a hypoglycemic episode arose later on, three or five hours later while the child is sleeping, then the technology would be there ready to deploy the therapeutic, correct the glucose imbalance and prevent a severe episode.”

Webber emphasized that the research is in extremely early stages and parents and individuals living with Type 1 diabetes should not expect to see such a therapeutic available in the near term.

“One of the big challenges was engineering the hydrogel to be stable enough in the presence of glucose and responsive enough in the absence of it,” he said. Another challenge was preventing the glucagon from leaking out of the hydrogel’s mesh-like structure. While the team was ultimately successful, Webber said he hopes to improve stability and responsiveness with further study.

###

Co-authors on the study include Sihan Yu, Sijie Xian, Zhou Ye and Irawan Pramudya, all at Notre Dame.

Webber’s work to develop new materials for blood glucose control is funded by the Leona M. and Harry B. Helmsley Charitable Trust, the American Diabetes Association and the Juvenile Diabetes Research Foundation.

Webber is an affiliate member of Notre Dame’s Institute for Precision Health and Harper Cancer Research Institute.

Media Contact
Jessica Sieff
[email protected]

Original Source

https://news.nd.edu/news/researchers-develop-novel-method-for-glucagon-delivery/

Tags: Biomedical/Environmental/Chemical EngineeringDiabetesTechnology/Engineering/Computer Science
Share13Tweet8Share2ShareShareShare2

Related Posts

Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

August 1, 2025
blank

Cancer-Associated Fibroblasts: Drivers of Drug Resistance

August 1, 2025

Technology Expert Emphasizes Continued Need for Human Touch in AI-Driven Healthcare Revolution

August 1, 2025

CCL2-CCR2 Axis Triggers ALS Neuromuscular Denervation

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    37 shares
    Share 15 Tweet 9
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Multimodal AI Predicts Thyroid Cancer Spread via Ultrasound

Cancer-Associated Fibroblasts: Drivers of Drug Resistance

Technology Expert Emphasizes Continued Need for Human Touch in AI-Driven Healthcare Revolution

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.